Back
Genscript Biotech Quote, Financials, Valuation and Earnings
Sponsored
GNNSF
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
65
GNNSF
Genscript Biotech
Last Price:
1.25
Seasonality Move:
-4.63%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...Genscript Biotech Price Quote
$1.25
Genscript Biotech Key Stats
Buy
65
Genscript Biotech (GNNSF)
is a Buy
Day range:
$1.25 - $1.25
52-week range:
$1.05 - $3.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.62
P/B ratio:
2.21%
Volume:
0
Avg. volume:
1.1K
1-year change:
-60.94%
Market cap:
$2.7B
Revenue:
$839.5M
EPS:
$-0.08
How Much Does Genscript Biotech Make?
-
How Much Are Genscript Biotech's Sales Annually?
GNNSF Revenues are $839.5M -
How Much Profit Does Genscript Biotech's Make A Year?
GNNSF net income is -$95.5M
Is Genscript Biotech Growing As A Company?
Data Unavailable
Genscript Biotech Stock Price Performance
-
Did Genscript Biotech Stock Go Up Last Month?
Genscript Biotech share price went down by -10.07% last month -
Did GNNSF's Share Price Rise Over The Last Year?
GNNSF share price fell by -60.94% over the past 1 year
What Is Genscript Biotech 52-Week High & Low?
-
What Is Genscript Biotech’s 52-Week High Share Price?
Genscript Biotech has traded as high as $3.20 over the past 52 weeks -
What Is Genscript Biotech’s 52-Week Low Share Price?
Genscript Biotech has traded as low as $1.05 over the past 52 weeks
Genscript Biotech Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Genscript Biotech?
-
How Much Debt Does Genscript Biotech Have?
Total long term debt quarterly is $336.1M -
How Much Cash Does Genscript Biotech Have?
Cash and short term investments quarterly total is $1.9B -
What Is Genscript Biotech’s Book Value Per Share?
Book value per share is 0.57
Is Genscript Biotech Cash Flow Positive?
-
What Is GNNSF Cash Flow From Operations?
Cash flow from operations (TTM) is -$19.9M -
What Is Genscript Biotech’s Cash Flow From Financing?
Cash flow from financing (TTM) is $53.8M -
What Is Genscript Biotech’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1B
Genscript Biotech Return On Invested Capital
-
Is Management Doing A Good Job?
GNNSF return on invested capital is -7.65% -
What Is Genscript Biotech Return On Assets?
ROA measures how assets are converting to revenues and is -5.26% -
What Is GNNSF Return On Equity?
ROE is a measure of profitability and is -8.92%
Genscript Biotech Earnings Date & Stock Price
-
What Is Genscript Biotech's Stock Price Today?
A single share of GNNSF can be purchased today for 1.25 -
What Is Genscript Biotech’s Stock Symbol?
Genscript Biotech trades on the otcm under the ticker symbol: GNNSF -
When Is Genscript Biotech’s Next Earnings Date?
The next quarterly earnings date for Genscript Biotech is scheduled on May 13, 2025 -
When Is GNNSF's next ex-dividend date?
Genscript Biotech's next ex-dividend date is June 5, 2017 -
How To Buy Genscript Biotech Stock?
You can buy Genscript Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Genscript Biotech Competitors
-
Who Are Genscript Biotech's Competitors?
Below is a list of companies who compete with Genscript Biotech or are related in some way:
Genscript Biotech Dividend Yield
-
What Is GNNSF Dividend Yield?
Genscript Biotech’s dividend yield currently is 0% -
What Is Genscript Biotech’s Payout Ratio?
Genscript Biotech’s payout ratio is 0% -
When Did Genscript Biotech Last Pay A Dividend?
The latest dividend pay date is December 14, 2024 -
What Is Genscript Biotech’s Dividend Per Share?
Genscript Biotech pays a dividend of $0.00 per share
Genscript Biotech Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |